Results 201 to 210 of about 83,505 (263)

Clinical Predictors of Response in Chronic Graft‐Versus‐Host Disease: Results From the “Predicting the Quality of Response to Specific Treatments (PQRST)” Trial

American Journal of Hematology, Volume 101, Issue 9, Page 2280-2287, September 2026.
ABSTRACT Despite significant progress in chronic GVHD therapies, challenges remain in understanding pleomorphic phenotypes and varying responses to treatment. The aim of this study was to identify predictors of treatment response. We conducted a prospective, observational cohort study of patients beginning first‐, second‐, or third‐line systemic ...
Betty K. Hamilton, Lynn Onstad, Paul A. Carpenter, Joseph Pidala, George Chen, Corey Cutler, Najla El Jurdi, Nosha Farhadfar, Mark Juckett, Carrie L. Kitko, Catherine J. Lee, Stephanie J. Lee   +11 more
wiley   +1 more source

Hodgkin Reed-Sternberg Cells of Classic Hodgkin Lymphoma: Morphology, Phenotype, Genotype, and Cell of Origin. [PDF]

Cancers (Basel)
Gloghini A, Lorenzini D, Volpi CC, Trupia DV, Pruneri G.   +4 more
europepmc   +1 more source

Payload‐Based Clinical Pharmacology Review of Approved Antibody–Drug Conjugates: Commonalities and Considerations for Streamlined Development

Clinical Pharmacology &Therapeutics, Volume 120, Issue 3, Page 614-638, September 2026.
Antibody–drug conjugates (ADCs) combine the specificity of an antibody with the potency of a cytotoxic drug. Thirteen ADCs, utilizing seven unique cytotoxic payloads and targeting 11 distinct antigens, are currently approved by the US Food and Drug Administration as of June 2025, representing a rapidly growing and highly promising class of anticancer ...
Sijie Lu, Qingqing Xiao, Lixuan Qian, Siyuan Sun, Zhu Zhou, Michael Z. Liao, Chunze Li   +6 more
wiley   +1 more source

Synchronous primary pulmonary extranodal NK/T-cell lymphoma and relapsed Hodgkin lymphoma occurring after chemotherapy for primary Hodgkin lymphoma: A case report and literature review. [PDF]

Rare Tumors
Corredor-Orlandelli D, Bohórquez L, Arévalo-Zambrano M.   +2 more
europepmc   +1 more source

Emphasizing the diagnostic and management challenge: Nodular sclerosis Hodgkin lymphoma with pericardial infiltration in an adolescent male - A case report. [PDF]

Leuk Res Rep
AbuGhannam SI, Andonie CR, Masalmeh LI, Karama A, Alresheq MZ, Khalili A.   +5 more
europepmc   +1 more source

Circulating miR-148a-3p Correlates with Inadequate Induction Response in Pediatric Hodgkin Lymphoma. [PDF]

Immunotargets Ther
Rohde M, Singh VK, Wolfermann A, Burkhardt B, Blattmann C, Steinbach D, Schneider DT, Ebinger M, Maecker-Kolhoff B, Braun M, Kurch L, Mauz-Körholz C, Körholz D.   +12 more
europepmc   +1 more source

Expression and prognostic value of FKBP51 in Hodgkin lymphoma. [PDF]

Front Immunol
Varricchio S, Romano S, Russo D, Travaglino A, Cappiello R, Cervasio M, Ilardi G, Marrone L, Pane F, Picardi M, Persico M, Vigliar E, Acanfora G, Romano MF, Mascolo M.   +14 more
europepmc   +1 more source

Quantitative longitudinal photoacoustic imaging of vascular oxygenation for therapy response monitoring in Non-Hodgkin lymphoma. [PDF]

Photoacoustics
Shi J, Fan Y, Mi J, Mao Q, Huang Y, Ta D, Feng T, Chen L.   +7 more
europepmc   +1 more source

Paraneoplastic Neuro-Ophthalmologic Symptoms as Initial Manifestation of Hodgkin Lymphoma. [PDF]

Hematol Rep
Seidenfaden SC, Adams TG, Kamper P, Jespersen S, Pedersen MB.   +4 more
europepmc   +1 more source

Geospatial Access to CAR-T Clinical Trials for Non-Hodgkin Lymphoma for Persons With HIV.

JAMA Netw Open
Maillie L, Sisk M, Coghill AE, Van Bibber N, Guerra CE, Aboulafia DM, Atkinson TM, Velazquez V, Barta SK.   +8 more
europepmc   +1 more source